Skip to content

Effects of Electrical Muscle Stimulation on Waist Circumference in Adults

Effects of Electrical Muscle Stimulation on Waist Circumference in Adults: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02970812
Enrollment
60
Registered
2016-11-22
Start date
2015-01-31
Completion date
2015-09-30
Last updated
2021-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Obesity

Brief summary

This randomized, placebo-controlled, double-blind, controlled study was designed to investigate the efficacy of electrical muscle simulation (EMS) for treatment of waist circumference (WC) reduction in abdominal obese adults. 60 patients with abdominal obese, man with WC \> 90 cm and woman with WC \> 80 cm, received EMS as experimental group (EG) or transcutaneous electrical nerve stimulation (TENS) as control group (CG) 5 times a week for 12 weeks.

Detailed description

Background: This randomized, placebo-controlled, double-blind, controlled study was designed to investigate the efficacy of electrical muscle simulation (EMS) for treatment of waist circumference (WC) reduction in abdominal obese adults. Methods: 60 patients with abdominal obese, man with WC \> 90 cm and woman with WC \> 80 cm, received EMS as experimental group (EG) or transcutaneous electrical nerve stimulation (TENS) as control group (CG) 5 times a week for 12 weeks.

Interventions

Participants were under EMS 5 times a week for 12 weeks. Pads were applied on participants' abdomen, rectus abdominis and external oblique abdominal muscle areas without any recent wound, infection, scar, and warts while lie on their back.

DEVICETranscutaneous Electrical Nerve Stimulation

Participants were under TENS 5 times a week for 12 weeks. Pads were applied on participants' abdomen, rectus abdominis and external oblique abdominal muscle areas without any recent wound, infection, scar, and warts while lie on their back.

Sponsors

Pusan National University Yangsan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject has abdominal obese seventy subjects between the age 18 and 65 years * Abdominal obesity was defined as having a waist circumference (WC) \>90 cm for men or WC \>80 cm for women was defined based on the Asia-Pacific criteria of the International Diabetes Federation.

Exclusion criteria

* pregnant or breastfeeding, had taken any treatment for weight loss or any medication known to affect weight * had a weight loss of 3% or more in the preceding 3 months, had undergone any major surgery during the 1 year prior to study commencement * had any inserted metallic materials including a pacemaker. * aspartate aminotransferase or alanine aminotransferase of 100 mg/dL or more * serum creatinine of 1.5 mg/dL or more * a history of coronary arterial disease or cerebrovascular disease, impairment of a major organ system, cancer, severe lung diseases, severe cerebral trauma, uncontrolled hypertension and psychiatric diseases including eating disorder, etc.

Design outcomes

Primary

MeasureTime frameDescription
Waist Circumference12 weeksWaist circumference was measured by a tape

Countries

South Korea

Participant flow

Participants by arm

ArmCount
Electrical Muscle Stimulation
EMS program was consisted of warm-up, warm-down, contraction and relaxation. It was programed to be resemble to actual muscle action of voluntary exercise. To increase energy consumption as high intensity exercise, tripled the contraction duration. EMS group used Program 3 and regulated intensity though channel from 1 to 4. EMS: Participants were under EMS 5 times a week for 12 weeks. Pads were applied on participants' abdomen, rectus abdominis and external oblique abdominal muscle areas without any recent wound, infection, scar, and warts while lie on their back.
30
Electrical Nerve Stimulation
Transcutaneous group used Transcutaneous Electrical Nerve Stimulation (TENS) which is the use of electric current produced to stimulate the sensory nerves to block pain signal. It is programed to applied currents regularly, once a second with a frequency of 1 Hz. TENS: Participants were under TENS 5 times a week for 12 weeks. Pads were applied on participants' abdomen, rectus abdominis and external oblique abdominal muscle areas without any recent wound, infection, scar, and warts while lie on their back.
30
Total60

Baseline characteristics

CharacteristicElectrical Nerve StimulationTotalElectrical Muscle Stimulation
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
30 Participants60 Participants30 Participants
Age, Continuous38.5 years
STANDARD_DEVIATION 10.6
39 years
STANDARD_DEVIATION 11
40 years
STANDARD_DEVIATION 12.9
CT visceral fat91.0 cm^2
STANDARD_DEVIATION 48.3
95.2 cm^2
STANDARD_DEVIATION 58.1
105.7 cm^2
STANDARD_DEVIATION 66.3
Region of Enrollment
South Korea
30 participants60 participants30 participants
Sex: Female, Male
Female
21 Participants46 Participants25 Participants
Sex: Female, Male
Male
9 Participants14 Participants5 Participants
Waist circumference92.3 cm
STANDARD_DEVIATION 7.2
92.2 cm
STANDARD_DEVIATION 9.6
92.2 cm
STANDARD_DEVIATION 11.6

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 30
other
Total, other adverse events
0 / 300 / 30
serious
Total, serious adverse events
0 / 300 / 30

Outcome results

Primary

Waist Circumference

Waist circumference was measured by a tape

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Electrical Muscle StimulationWaist Circumference87.0 cmStandard Deviation 12.4
Electrical Nerve StimulationWaist Circumference89.4 cmStandard Deviation 9.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026